• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人戈谢病脾脏中分离出两种参与鞘磷脂酶促降解的激活蛋白。

Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen.

作者信息

Christomanou H, Kleinschmidt T

出版信息

Biol Chem Hoppe Seyler. 1985 Mar;366(3):245-56. doi: 10.1515/bchm3.1985.366.1.245.

DOI:10.1515/bchm3.1985.366.1.245
PMID:4005041
Abstract

Two activator proteins for sphingomyelin degradation were isolated from heat-treated extracts of human Gaucher spleen. The separation was based on the degree of affinity of the activators for ConA-Sepharose. Activator A1, which had affinity for ConA-Sepharose, was purified 1 430-fold, and activator A2, which had no affinity for ConA-Sepharose, 2 140-fold as compared with the original heat-treated extracts. The molecular masses of activator A1 and activator A2 were 6 000 and 3 500 Da, respectively, as determined by dodecyl sulfate electrophoresis, and approximately 5 000 Da as measured in the presence of 8M urea. The two activators had similar properties and a similar but not identical amino-acid composition. Both were shown to form a complex with sphingomyelin and stimulate the degradation of sphingomyelin by normal fibroblast homogenates and by an approximately 1 430-fold purified sphingomyelin phosphodiesterase ("acid sphingomyelinase") from normal human urine. This stimulation was greatly reduced after incubation with pronase E. The enzymic degradation of glucosylceramide and galactosylceramide was not affected by these activators.

摘要

从经热处理的戈谢病患者脾脏提取物中分离出两种鞘磷脂降解激活蛋白。分离基于激活蛋白与刀豆球蛋白A-琼脂糖的亲和程度。与原始经热处理的提取物相比,对刀豆球蛋白A-琼脂糖有亲和力的激活蛋白A1纯化了1430倍,对刀豆球蛋白A-琼脂糖无亲和力的激活蛋白A2纯化了2140倍。通过十二烷基硫酸钠电泳测定,激活蛋白A1和激活蛋白A2的分子量分别为6000和3500道尔顿,在8M尿素存在下测量约为5000道尔顿。这两种激活蛋白具有相似的性质和相似但不完全相同的氨基酸组成。二者均显示与鞘磷脂形成复合物,并刺激正常成纤维细胞匀浆以及来自正常人尿液的经约1430倍纯化的鞘磷脂磷酸二酯酶(“酸性鞘磷脂酶”)对鞘磷脂的降解。与链霉蛋白酶E孵育后,这种刺激作用大大降低。这些激活蛋白对葡糖神经酰胺和半乳糖神经酰胺的酶促降解没有影响。

相似文献

1
Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen.从人戈谢病脾脏中分离出两种参与鞘磷脂酶促降解的激活蛋白。
Biol Chem Hoppe Seyler. 1985 Mar;366(3):245-56. doi: 10.1515/bchm3.1985.366.1.245.
2
Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.体外刺激酶促鞘磷脂降解的两种激活蛋白的免疫化学特性。人类戈谢病变异体中其中一种蛋白的缺失。
Biol Chem Hoppe Seyler. 1986 Sep;367(9):879-90. doi: 10.1515/bchm3.1986.367.2.879.
3
Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.尼曼-匹克病C型:刺激鞘磷脂和葡萄糖脑苷脂降解的激活因子缺乏的证据
Hoppe Seylers Z Physiol Chem. 1980 Oct;361(10):1489-502. doi: 10.1515/bchm2.1980.361.2.1489.
4
Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.鞘磷脂脂质体酶促水解的激活研究。
Biochim Biophys Acta. 1984 Apr 18;793(2):141-8. doi: 10.1016/0005-2760(84)90315-1.
5
Complete amino-acid sequence of the naturally occurring A2 activator protein for enzymic sphingomyelin degradation: identity to the sulfatide activator protein (SAP-1).用于酶促鞘磷脂降解的天然存在的A2激活蛋白的完整氨基酸序列:与硫苷脂激活蛋白(SAP-1)相同。
Biol Chem Hoppe Seyler. 1988 Dec;369(12):1361-5. doi: 10.1515/bchm3.1988.369.2.1361.
6
A protein activator of galactosylceramide beta-galactosidase.半乳糖神经酰胺β-半乳糖苷酶的一种蛋白质激活剂。
Biochim Biophys Acta. 1982 Sep 14;712(3):639-49. doi: 10.1016/0005-2760(82)90293-4.
7
Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.戈谢病脾脏鞘脂激活蛋白2多种形式的分析。
Biochem J. 1988 Aug 15;254(1):77-84. doi: 10.1042/bj2540077.
8
Human lysosomal sphingomyelinase: substrate efficacy of apolipoprotein/sphingomyelin complexes.人溶酶体鞘磷脂酶:载脂蛋白/鞘磷脂复合物的底物效能。
Biochemistry. 1986 Jul 29;25(15):4415-20. doi: 10.1021/bi00363a036.
9
N-terminal amino-acid sequence of a sphingolipid activator protein missing in a new human Gaucher disease variant.一种新的人类戈谢病变体中缺失的鞘脂激活蛋白的N端氨基酸序列。
Biol Chem Hoppe Seyler. 1987 Sep;368(9):1193-6. doi: 10.1515/bchm3.1987.368.2.1193.
10
Acid sphingomyelinase from human urine: purification and characterization.人尿酸性鞘磷脂酶:纯化与特性分析
Biochim Biophys Acta. 1987 Dec 14;922(3):323-36. doi: 10.1016/0005-2760(87)90055-5.

引用本文的文献

1
Prosaposin: A Multifaceted Protein Orchestrating Biological Processes and Diseases.鞘脂激活蛋白原:一种协调生物过程与疾病的多功能蛋白质。
Cells. 2025 Jul 22;14(15):1131. doi: 10.3390/cells14151131.
2
Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.前体蛋白缺乏症:鞘脂激活蛋白缺乏的同胞的进一步特征。这种全身性鞘脂贮积病中多种糖脂升高(包括乳糖基神经酰胺沉积症)、部分酶缺乏及皮肤超微结构。
Hum Genet. 1993 Sep;92(2):143-52. doi: 10.1007/BF00219682.
3
Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.
II型和III型粘脂贮积症中戈谢激活因子生物合成过程中加工错误的初步证据。
Biochem J. 1986 Feb 1;233(3):763-72. doi: 10.1042/bj2330763.
4
Analysis of the multiple forms of Gaucher spleen sphingolipid activator protein 2.戈谢病脾脏鞘脂激活蛋白2多种形式的分析。
Biochem J. 1988 Aug 15;254(1):77-84. doi: 10.1042/bj2540077.
5
Saposin A: second cerebrosidase activator protein.
Proc Natl Acad Sci U S A. 1989 May;86(9):3389-93. doi: 10.1073/pnas.86.9.3389.
6
Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.激活蛋白缺陷型戈谢病。第二例新确诊的脂质贮积病患者。
Klin Wochenschr. 1989 Oct 2;67(19):999-1003. doi: 10.1007/BF01716064.
7
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.
Eur J Pediatr. 1989 Oct;149(1):31-9. doi: 10.1007/BF02024331.
8
Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.芳基硫酸酯酶A活性正常的异染性脑白质营养不良中的鞘脂激活蛋白1缺乏症。一项临床、形态学、生化和免疫学研究。
Eur J Pediatr. 1991 Jun;150(8):584-91. doi: 10.1007/BF02072213.
9
Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.一名患者及其患有鞘脂激活蛋白(SAP)前体—— prosaposin基因缺陷的胎儿同胞的其他生化检查结果。证明存在SAP-1缺乏以及溶酶体神经氨酸酶正常。
Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):481-8. doi: 10.1042/bj2850481.
10
Evidence for two cDNA clones encoding human GM2-activator protein.编码人GM2激活蛋白的两个cDNA克隆的证据。
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):807-13. doi: 10.1042/bj2820807.